Switch View
© BusinessWire
11.11.2025
ISIN: US6047491013
Mirum Pharmaceuticals Inc
TKOMF
LISTED
OTC
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM) today announced that on November 10, 2025, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 53,500 shares of common stock and 27,950 restricted stock units (“RSUs”) to 11 new employees under Mirum’s 2020 Inducement Pla...
Themefolio
Profiler
Peergroup
© Newsfile
11.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Baxter International Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BAX
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Baxter International Inc. (NYSE: BAX) between February 23, 2022 and July 30, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline.SO WHAT...
Themefolio
Profiler
Peergroup
© Newsfile
11.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages aTyr Pharma, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ATYR
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of aTyr Pharma, Inc. (NASDAQ: ATYR) between January 16, 2025 and September 12, 2025, both dates inclusive (the "Class Period"), of the important December 8, 2025 lead plaintiff deadline.SO WHAT:...
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Newsfile
11.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
ROSEN, A RANKED AND LEADING FIRM, Encourages Avantor, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - AVTR
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of common stock of Avantor, Inc. (NYSE: AVTR) between March 5, 2024 and October 28, 2025, both dates inclusive (the "Class Period"). A class action lawsuit has...
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Newsfile
11.11.2025
ISIN: US0718131099
Baxter International, Inc.
BAX
LISTED
NYSE
BAX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Baxter International
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Baxter To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Baxter between February 23, 2022 and July 30, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2025
ISIN: US8688731004
Surmodics Inc
SRDX
LISTED
NASDAQ
Surmodics Announces U.S. District Court Denies Request for Preliminary Injunction to Block Proposed Acquisition by GTCR
News Preview
Surmodics, Inc. (Nasdaq: SRDX) (“Surmodics” or the “Company”), a leading provider of medical device and in vitro diagnostic technologies to the health care industry, today announced that the United States District Court for the Northern District of Illinois (the “District Court”) has denied a request by the U.S. Federal Trade Commission (the “FTC”...
Themefolio
Profiler
Peergroup
© Newsfile
11.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
MOH INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Molina Healthcare
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Molina To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Molina between February 5, 2025 and July 23, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© Newsfile
11.11.2025
ISIN: US4718712023
Jasper Therapeutics, Inc.
JSPR
LISTED
NASDAQ
JSPR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Jasper To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Jasper between November 30, 2023 and July 3, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Securities Fraud Investigation Into Inspire Medical Systems, Inc. (INSP) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm
News Preview
Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) investors concerning the Company’s possible violations of the federal securities laws.
IF YOU ARE AN INVESTOR WHO LOST MONEY O...
Themefolio
Profiler
Peergroup
© Newsfile
11.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
MLTX INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of MoonLake Immunotherapeutics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In MoonLake To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in MoonLake between March 10, 2024 and September 29, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partne...
Themefolio
Profiler
Peergroup
© Newsfile
11.11.2025
ISIN: US23282W6057
Cytokinetics Inc
CYTK
LISTED
NASDAQ
CYTK INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Cytokinetics
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Cytokinetics To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Cytokinetics between December 27, 2023 and May 6, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi pa...
Themefolio
Profiler
Peergroup
© BusinessWire
11.11.2025
ISIN: AU000000TLX2
Telix Pharmaceuticals Ltd
TLX
LISTED
ASX
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Telix Pharmaceuticals Ltd. Investors – TLX
News Preview
Rosen Law Firm, a global investor rights law firm, announces it has filed a class action lawsuit on behalf of purchasers of the securities of Telix Pharmaceuticals Ltd. (NASDAQ: TLX) between February 21, 2025 and August 28, 2025, both dates inclusive (the “Class Period”). The lawsuit seeks to recover damages for Telix investors under the federal s...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Newsfile
10.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
AVTR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Avantor
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered In Avantor To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Avantor between March 5, 2024 and October 28, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilso...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages agilon health, inc. Investors to Inquire About Securities Class Action Investigation - AGL
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of agilon health, inc. (NYSE: AGL) resulting from allegations that agilon health may have issued materially misleading business information to the inve...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INSP INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Inspire Medical Systems
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Inspire Medical To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in Inspire Medical between August 6, 2024 and August 4, 2025 and would like to discuss your legal rights, call Faruqi & Far...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US0021202025
Atyr Pharma, Inc.
ATYR
LISTED
NASDAQ
ATYR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of aTyr Pharma
News Preview
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In aTyr To Contact Him Directly To Discuss Their OptionsIf you purchased or acquired securities in aTyr between January 16, 2025 and September 12, 2025 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US15135B1017
Centene Corp
CNC
LISTED
NYSE
Wellcare Enhances Offering of Affordable, Quality Medicare Advantage and Medicare Prescription Drug Plans in 2026
News Preview
Medicare Advantage plans will be available to more than 51 million beneficiaries in 32 states; Prescription Drug Plans will continue to be offered nationwide
New in 2026
Wellcare to transition Medicare-Medicaid Plans (MMPs) demonstrations to i...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US00973Y1082
Akero Therapeutics Inc
AKRO
LISTED
NASDAQ
$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger-CRTAF, AKRO, NIC, and BRNS
News Preview
NEW YORK, Nov. 10, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a Top 50 Firm in the 2024 ISS Securities Class Action Services Report. We are headquartered a...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
INSP BREAKING: Inspire Medical Systems, Inc. Inspire V Delays Trigger Securities Fraud Class Action after Stock Drops 32% -- Investors are Urged to Contact BFA Law
News Preview
Leading securities law firm Bleichmar Fonti & Auld LLP announces that a class action lawsuit has been filed against Inspire Medical Systems, Inc. (NYSE: INSP) and certain of the Company’s senior executives for securities fraud after a significant stock drop resulting from the potential violations of the federal securities laws.
If you invest...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: CA57384M1077
Marvel Biosciences Corp.
MRVL
LISTED
TSX
Marvel Biosciences Announces Grant of Deferred Share Units
News Preview
Calgary, Alberta--(Newsfile Corp. - November 10, 2025) - Marvel Biosciences Corp. (TSXV: MRVL) and its wholly owned subsidiary, Marvel Biotechnology Inc. (collectively the "Company" or "Marvel"), announces the award of 35,697 deferred share units ("DSUs") to Marvel's three independent directors, in lieu of cash payment for directors' fees.The DSUs...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: CA58504D1006
Medipharm Labs Corp
LABS
LISTED
TSX
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
News Preview
MediPharm will release its third quarter financial results before markets open on Thursday, November 13th, 2025....
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US89422G1076
Travere Therapeutics Inc
TVTX
LISTED
NASDAQ
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
Travere Therapeutics, Inc. (NASDAQ: TVTX) today announced that on November 10, 2025, the Compensation Committee of its Board of Directors granted inducement equity grants to three new employees, consisting of inducement restricted stock units, or RSUs, covering an aggregate of 25,700 shares of its common stock. These inducement RSUs are subject to...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: CA25380E1060
Digicann Ventures Inc.
DCNN
LISTED
CSE
CSE Bulletin: Resumption and Symbol Change - Inactive Designation - Digicann Ventures Inc. (DCNN)
News Preview
Toronto, Ontario--(Newsfile Corp. - Le 10 novembre/November 2025) - Digicann Ventures Ltd. (the “Issuer”) has announced a termination, settlement and release agreement with 3Win Corp. and D-3 Merger Sub Inc. to mutually terminate the business combination agreement dated Sept. 27, 2024. The Exchange has determine...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US29261A1007
Encompass Health Corp
EHC
LISTED
NYSE
Rehabilitation Hospital of Amarillo now open in Texas
News Preview
The 50-bed inpatient rehabilitation hospital is a joint venture between Encompass Health and BSA Health System.
BIRMINGHAM, Ala. and AMARILLO, Texas, Nov. 10, 2025 /PRNewswire/ -- Today, Encompass Health, the nation's largest owner and operator of inpatient reha...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US76200L3096
Rezolute, Inc.
RZLT
LISTED
NASDAQ
Rezolute Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
News Preview
REDWOOD CITY, Calif., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Rezolute, Inc. (NASDAQ: RZLT), (“Rezolute” or the “Company”), a late-stage rare disease company focused on treating hypoglycemia caused by hyperinsulinism, today announced that it has granted as of October 31, 2025 equity inducement awards to two new employees. The equity awards were approve...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US4834971032
Kalvista Pharmaceuticals Inc
KALV
LISTED
NASDAQ
KalVista Pharmaceuticals Provides Operational Update and Reports Third Quarter Financial Results
News Preview
KalVista Pharmaceuticals, Inc. (Nasdaq: KALV), today provided an operational update and reported financial results for the third quarter ended September 30, 2025.
“The US launch of EKTERLY is progressing with significant momentum, driven by strong early demand and rapid adoption among physicians and people living with HAE. We continue to see enc...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US45685K1025
InfuSystem Holdings Inc
INFU
LISTED
XASE
InfuSystem to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18, 2025
News Preview
InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”),a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today Carrie Lachance, President and Chief Executive Officer and Barry Steele, Chief Financial Officer, will p...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US20603L1026
Concentra Group Holdings Parent, Inc.
CON
LISTED
NASDAQ
Concentra Appoints Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer
News Preview
Concentra®, (NYSE: CON) the nation’s largest provider of occupational health services, today announced the appointment of Jason Cooper as Chief Data, Analytics, and Artificial Intelligence Officer. In this role, he will ensure Concentra’s data strategy and governance, technology enablement, and insight generation are aligned with enterprise growth...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US04546C2052
Assertio Holdings Inc
ASRT
LISTED
NASDAQ
Assertio Reports Third Quarter 2025 Financial Results
News Preview
Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the third quarter ended September 30, 2025.
Mark Reisenauer, Chief Executive Officer, stated: “In the...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: KYG8807B1068
Theravance Biopharma Inc
TBPH
LISTED
NASDAQ
Theravance Biopharma, Inc. Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
YUPELRI® net sales reached an all-time high of $71.4 million, recognized by Viatris, up 15% year-over-year
1
, and achieved record brand profitability...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US45773H4092
Inovio Pharmaceuticals Inc
INO
LISTED
NASDAQ
INOVIO Reports Third Quarter 2025 Financial Results and Recent Business Highlights
News Preview
Completed rolling Biologics License Application (BLA) submission seeking accelerated approval for lead candidate INO-3107; requested priority review
Expect to receive file acceptance by year end 2025 with potential PDUFA date in mid-2...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US05370A1088
Avidity Biosciences Inc
RNA
LISTED
NASDAQ
Avidity Biosciences Reports Third Quarter 2025 Financial Results and Recent Highlights
News Preview
Announced Novartis agreement to acquire Avidity for total equity value of approximately $12 billion; Avidity expects to separate its early-stage precision cardiology programs into a new public company ("SpinCo")
Clear path forward aligned with FDA following pre-...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US64125C1099
Neurocrine Biosciences Inc
NBIX
LISTED
NASDAQ
Neurocrine Biosciences Provides Update on Phase 2 Study of NBI-1070770 in Adults with Major Depressive Disorder
News Preview
SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that its Phase 2 study evaluating the efficacy, safety and tolerability of investigational compound NBI-1070770 in adults with major depressive disorder did not meet the primary endpoint compared to placebo. NBI-1...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US85209E1091
Spruce Biosciences Inc
SPRB
LISTED
OTC
Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
News Preview
Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders with significant unmet medical need, today reported financial results for the third quarter ended September 30, 2025 and provided corporate updates.
“We have made significant progres...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US62857J2015
Myomo, Inc.
MYO
LISTED
XASE
Myomo Reports Third Quarter 2025 Financial and Operating Results
News Preview
Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today reported financial results for the three and nine months ended September 30, 2025.
“Third quarter revenues were at the high end of our...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US2560861096
DocGo Inc
DCGO
LISTED
NASDAQ
DocGo Announces Third Quarter 2025 Results
News Preview
DocGo Inc. (Nasdaq: DCGO) (“DocGo” or the “Company”), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025.
Third Quarter 2025 Financial Highlights
Total revenue for the third quarter of 2025 was $70.8 million, compa...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US22053A1079
Quince Therapeutics Inc
CRTX
LISTED
NASDAQ
Quince Therapeutics Announces Positive iDSMB Review for eDSP in Pivotal Phase 3 NEAT Clinical Trial in Ataxia-Telangiectasia
News Preview
Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced the positive outcome of its pre-planned safety analysis conducted by an independent data and safety monitoring board (iDSMB) for the company’s ongoing pivotal P...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US42225T1079
Health Catalyst Inc
HCAT
LISTED
NASDAQ
UnityPoint Health to Unlock Next Phase of Analytics Innovation by Activating Health Catalyst Ignite™
News Preview
SALT LAKE CITY, Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that UnityPoint Health, an integrated non-profit health system that provides care throughout Iowa, we...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US42225T1079
Health Catalyst Inc
HCAT
LISTED
NASDAQ
Health Catalyst Achieves HITRUST r2 Certification, Demonstrating the Highest Level of Information Protection Assurance
News Preview
SALT LAKE CITY, Nov. 10, 2025 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Twistle by Health Catalyst (Twistle), Lumeon by Health Catalyst (Lumeon), and Upfront by Health...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US03969T1097
Arcturus Therapeutics Holdings Inc
ARCT
LISTED
NASDAQ
Arcturus Therapeutics Announces Third Quarter 2025 Financial Update and Pipeline Progress
News Preview
Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a commercial messenger RNA medicines company focused on the development of liver and respiratory rare disease therapeutics and infectious disease vaccines, today announced its financial results for the third quarter ended September 30, 2025, and provided corporate updat...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US98401F1057
Xencor Inc
XNCR
LISTED
NASDAQ
Xencor to Participate at Upcoming Investor Conferences
News Preview
Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today announced that company management will participate at multiple upcoming investor conferences:
TD Cowen Immunology and Inflammation Virtual Summit
Date: Wednesday, November 12, 2025
P...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US74766Q1013
Quanterix Corp
QTRX
LISTED
NASDAQ
Quanterix Releases Financial Results for the Third Quarter of 2025
News Preview
Quanterix Corporation (NASDAQ: QTRX), a company transforming healthcare by accelerating biomarker breakthroughs from discovery to diagnostics, today announced financial results for the third quarter ended September 30, 2025.
“During the third quarter, we delivered on our revenue expectations despite challenging market conditions,” said Masoud To...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US04351N1063
Ascend Wellness Holdings, Inc
AAWH.U
LISTED
CSE
AWH Announces Third Quarter 2025 Financial Results
News Preview
Delivered Q3 2025 Net Revenue of $124.7 million
Achieved Q3 2025 Adjusted
EBITDA1 of $31.1 million, representing a 24.9% margin
Focused margin optimization fueled sequential Adjusted Gross M...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US04351N1063
Ascend Wellness Holdings, Inc
AAWH.U
LISTED
CSE
AWH Announces Third Quarter 2025 Financial Results
News Preview
Delivered Q3 2025 Net Revenue of $124.7 million
Achieved Q3 2025 Adjusted
EBITDA1 of $31.1 million, representing a 24.9% margin
Focused margin optimization fueled sequential Adjusted Gross M...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Inspire Medical Systems, Inc. (INSP) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
News Preview
Law Offices of Howard G. Smith announces an investigation on behalf of Inspire Medical Systems, Inc. (“Inspire” or the “Company”) (NYSE: INSP) investors concerning the Company’s possible violations of federal securities laws.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN INSPIRE MEDICAL SYSTEMS, INC. (INSP), CONTACT THE LAW OFFICES OF HOWARD G....
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US60855R1005
Molina Healthcare Inc
MOH
LISTED
NYSE
Ongoing Securities Investigation into Molina Healthcare, Inc. (MOH) - Contact Levi & Korsinsky
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE: MOH) concerning possible violations of federal securities laws.On October 23, 2025, Molina published its third quarter, fiscal 2025 earnings well belo...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Securities Lawsuit Alert: Inspire Medical Systems, Inc. (INSP) Investors - Contact Levi & Korsinsky Before January 5, 2026
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - If you suffered a loss on your Inspire Medical Systems, Inc. (NYSE: INSP) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information:https://zlk.com/pslra-1/inspire-medical-systems-inc-lawsuit-submission-form?prid=17...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US22663K1079
Crinetics Pharmaceuticals Inc
CRNX
LISTED
NASDAQ
Crinetics Pharmaceuticals Announces November 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
News Preview
SAN DIEGO, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX) today announced that on November 10, 2025, the Compensation Committee of the Board of Directors granted non-qualified stock option awards to purchase an aggregate of 37,675 shares of its common stock and granted an aggregate of 25,300 restricted stock unit...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US68572M1062
Orchestra Biomed Holdings Inc
OBIO
LISTED
NASDAQ
Orchestra BioMed Reports Third Quarter 2025 Financial Results and Highlights Recent Business Updates
News Preview
NEW HOPE, Pa., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced financial results for the third quarter ended September 30, 2025, and provided a busi...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US8257041090
SI-BONE Inc
SIBN
LISTED
NASDAQ
SI-BONE, Inc. Reports Financial Results for the Third Quarter 2025 and Raises 2025 Guidance
News Preview
Delivered ~21% worldwide revenue growth, ~5% adjusted EBITDA margin, and positive cash from operating activities in the quarter...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US98943L1070
Zentalis Pharmaceuticals Inc
ZNTL
LISTED
NASDAQ
Zentalis Pharmaceuticals Reports Third Quarter 2025 Financial Results and Operational Progress
News Preview
DENALI Phase 2 trial evaluating azenosertib in patients with Cyclin E1-positive PROC remains on track with topline data anticipated by year end 2026, with the potential to support an accelerated approval, subject to FDA feedback...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.11.2025
ISIN: US6031701013
Mineralys Therapeutics Inc
MLYS
LISTED
NASDAQ
Mineralys Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News Preview
– Submission of New Drug Application (NDA) for lorundrostat planned for late-2025/Q1 2026 –...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US00857U1079
agilon health inc
AGL
LISTED
NYSE
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Agilon Health, Inc. (NYSE: AGL) and Encourages Investors with Substantial Losses to Contact the Firm
News Preview
NEWTOWN, Pa., Nov. 10, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Agilon Health, Inc. ("Agilon" or "the Company") (NYSE: AGL), resulting from allegations of providing potentially misleading business information to the investing public....
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US8342033094
Soleno Therapeutics Inc
SLNO
LISTED
NASDAQ
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO) and Encourages Investors with Substantial Losses or Witnesses with Relevant Information to Contact the Firm
News Preview
NEWTOWN, Pa., Nov. 10, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Soleno Therapeutics, Inc. ("Soleno" or "the Company") (NASDAQ: SLNO), resulting from allegations of providing potentially misleading business information to the investing...
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US03969T1097
Arcturus Therapeutics Holdings Inc
ARCT
LISTED
NASDAQ
INVESTIGATION ALERT: Edelson Lechtzin LLP Announces Investigation of Arcturus Therapeutics Holdings Inc. (NASDAQ: ARCT) and Encourages Investors with Substantial Losses to Contact the Firm
News Preview
NEWTOWN, Pa., Nov. 10, 2025 /PRNewswire/ -- Edelson Lechtzin LLP is investigating potential violations of the federal securities laws involving Arcturus Therapeutics Holdings Inc. ("Arcturus") (NASDAQ: ARCT), resulting from allegations of providing potentially misleading business information to the investing publ...
Themefolio
Profiler
Peergroup
© BusinessWire
10.11.2025
ISIN: US05352A1007
Avantor Inc
AVTR
LISTED
NYSE
Deadline Alert: Avantor, Inc. (AVTR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit
News Preview
Glancy Prongay & Murray LLP reminds investors of the upcoming December 29, 2025 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Avantor, Inc. (“Avantor” or the “Company”) (NYSE: AVTR) common stock between March 5, 2024 and October 28, 2025, inclusive (the “Class Peri...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US8753722037
Tandem Diabetes Care Inc
TNDM
LISTED
NASDAQ
ROSEN, A LEADING LAW FIRM, Encourages Tandem Diabetes Care, Inc. Investors to Inquire About Securities Class Action Investigation - TNDM
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Tandem Diabetes Care, Inc. (NASDAQ: TNDM) resulting from allegations that Tandem Diabetes Care may have issued materially misleading business inform...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Inspire Medical Systems, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - INSP
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of common stock of Inspire Medical Systems, Inc. (NYSE: INSP) between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"). A class action lawsuit ha...
Themefolio
Profiler
Peergroup
© Newsfile
10.11.2025
ISIN: KY61559X1045
MoonLake Immunotherapeutics
MLTX
LISTED
NASDAQ
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages MoonLake Immunotherapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - MLTX
News Preview
New York, New York--(Newsfile Corp. - November 10, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, both dates inclusive (the "Class Period"), of the important December 15, 2025 lead plaintiff deadline....
Themefolio
Profiler
Peergroup
© PR Newswire
10.11.2025
ISIN: US4577301090
Inspire Medical Systems Inc
INSP
LISTED
NYSE
Robbins Geller Rudman & Dowd LLP Announces that Inspire Medical Systems, Inc. (INSP) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
News Preview
SAN DIEGO, Nov. 10, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Inspire Medical Systems, Inc. (NYSE: INSP) common stock between August 6, 2024 and August 4, 2025, both dates inclusive (the "Class Period"), have until January 5, 2026 to seek a...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
More information, click here
More sector specific news
Your Press Release is missing or you want share news over GICS11? Drop us a line.
